Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/1VT stock hub

FRA/1VT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/1VTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.1B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/1VT

In the news

Latest news · FRA/1VT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-70

P25 n/aP50 n/aP75 n/a

ROIC-46.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/1VT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

134

Groups with data

Currency

USD

Showing 134 of 134 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	59
Employees Change	17%
Employees Change Percent	47.22
Enterprise value	EUR 2.6B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 3.1B
Price	EUR 27.15
Price currency	EUR
Sic	2836
Symbol	fra/1VT
Website	https://www.vikingtherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.26%
EV Earnings	-6.29x
P/B ratio	7.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -409.7M
Profit Per Employee	EUR -6.9M
ROA	-42.54
Roa5y	-21.32
ROCE	-100
ROE	-70.04
Roe5y	-32.87
ROIC	-46.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	38.42%
Cagr1y	11.9%
Cagr3y	10.39%
Cagr5y	41.34%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 527.5M
Cash	EUR 523M
Current Assets	EUR 515.7M
Current Liabilities	EUR 90.2M
Equity	EUR 435.3M
Interest Coverage	-15,687.2
Liabilities	EUR 92.2M
Long Term Assets	EUR 11.8M
Long Term Liabilities	EUR 2.1M
Net Cash	EUR 523M
Net Cash By Market Cap	EUR 16.92
Net Cash Growth	-29.13%
Net Debt Equity	EUR -1.2
Tangible Book Value	EUR 435.3M
Tangible Book Value Per Share	EUR 3.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.72
Net Working Capital	EUR -87.7M
Quick ratio	5.67
Working Capital	EUR 435.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	2,480.8%
1Y total return	11.89%
200-day SMA	27.92
3Y total return	34.54%
50-day SMA	28.55
50-day SMA vs 200-day SMA	50over200
5Y total return	463.98%
All Time High	91.5
All Time High Change	-70.33%
All Time High Date	2024-02-28
All Time Low	0.77
All Time Low Change	3,425.97%
All Time Low Date	2017-08-03
ATR	0.85
Ch YTD	-13.96
High	27.15
High52	39.1
High52 Date	2025-08-19
High52ch	-30.55%
Low	27.15
Low52	19.28
Low52 Date	2025-09-18
Low52ch	40.82%
Ma50ch	-4.9%
Price vs 200-day SMA	-2.77%
RSI	44.24
RSI Monthly	47.82
RSI Weekly	47.48
Sharpe ratio	0.45x
Sortino ratio	0.68
Total Return	-2.12%
Tr YTD	-13.96
Tr1m	-6.54%
Tr1w	-1.99%
Tr3m	14.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -435.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	113,281,384%
Shares Insiders	2.39%
Shares Institutions	63.31%
Shares Qo Q	1.37%
Shares Yo Y	2.12%
Short Ratio	9.09

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	307.55x
Bv Per Share	3.76
Ch10y	2,480.8
Ch1m	-6.54
Ch1w	-1.99
Ch1y	11.89
Ch3m	14.56
Ch3y	34.54
Ch5y	464
Ch6m	-11.71
Change	0.74%
Change From Open	0
Close	26.95
Days Gap	0.74
Depreciation Amortization	343,424.6
Dollar Volume	407.3
Earnings Date	2026-04-29
EBIT	EUR -435.4M
EPS	EUR -3.61
F Score	1
Financing CF	76,467,239
Fiscal Year End	December
Founded	2,012
Investing CF	288,231,544
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Ma150	28.79
Ma150ch	-5.68%
Ma20	28.47
Ma20ch	-4.63%
Net CF	69,536,645
Next Earnings Date	2026-07-22
Open	27.15
Price Date	2026-05-08
Ptbv Ratio	7.1
Relative Volume	0.05x
Share Based Comp	34,524,611
Tr6m	-11.71%
Volume	15

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/1VT pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/1VT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/1VT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+63.3%

Share of float held by funds and institutions

Insider ownership

+2.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/1VT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.2

Neutral momentum band

Price vs 200-day MA

-2.8%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.45

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/1VT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/1VT stock rating?

fra/1VT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/1VT analysis?

The full report lives at /stocks/fra/1VT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/1VT?

The latest report frames fra/1VT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/1VT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.